| RAS/ERK signaling promotes site-specific ribosomal protein S6 phosphorylation via RSK and stimulates cap-dependent translation PP Roux, D Shahbazian, H Vu, MK Holz, MS Cohen, J Taunton, ... Journal of Biological Chemistry 282 (19), 14056-14064, 2007 | 956 | 2007 |
| The mTOR/PI3K and MAPK pathways converge on eIF4B to control its phosphorylation and activity D Shahbazian, PP Roux, V Mieulet, MS Cohen, B Raught, J Taunton, ... The EMBO journal 25 (12), 2781-2791, 2006 | 729 | 2006 |
| Phosphorylation of eucaryotic translation initiation factor 4B Ser422 is modulated by S6 kinases B Raught, F Peiretti, AC Gingras, M Livingstone, D Shahbazian, ... The EMBO journal 23 (8), 1761-1769, 2004 | 646 | 2004 |
| The CC chemokine RANTES in breast carcinoma progression: regulation of expression and potential mechanisms of promalignant activity E Azenshtein, G Luboshits, S Shina, E Neumark, D Shahbazian, M Weil, ... Cancer research 62 (4), 1093-1102, 2002 | 492 | 2002 |
| mRNA helicases: the tacticians of translational control A Parsyan, Y Svitkin, D Shahbazian, C Gkogkas, P Lasko, WC Merrick, ... Nature reviews Molecular cell biology 12 (4), 235-245, 2011 | 418 | 2011 |
| mTOR signaling: implications for cancer and anticancer therapy E Petroulakis, Y Mamane, O Le Bacquer, D Shahbazian, N Sonenberg British journal of cancer 94 (2), 195-199, 2006 | 275 | 2006 |
| Yes-associated protein mediates immune reprogramming in pancreatic ductal adenocarcinoma S Murakami, D Shahbazian, R Surana, W Zhang, H Chen, GT Graham, ... Oncogene 36 (9), 1232-1244, 2017 | 235 | 2017 |
| eIF4B controls survival and proliferation and is regulated by proto-oncogenic signaling pathways D Shahbazian, A Parsyan, E Petroulakis, JWB Hershey, N Sonenberg Cell cycle 9 (20), 4106-4109, 2010 | 174 | 2010 |
| Control of cell survival and proliferation by mammalian eukaryotic initiation factor 4B D Shahbazian, A Parsyan, E Petroulakis, I Topisirovic, Y Martineau, ... Molecular and cellular biology 30 (6), 1478-1485, 2010 | 170 | 2010 |
| p53-dependent translational control of senescence and transformation via 4E-BPs E Petroulakis, A Parsyan, RJO Dowling, O LeBacquer, Y Martineau, ... Cancer cell 16 (5), 439-446, 2009 | 143 | 2009 |
| The helicase protein DHX29 promotes translation initiation, cell proliferation, and tumorigenesis A Parsyan, D Shahbazian, Y Martineau, E Petroulakis, T Alain, O Larsson, ... Proceedings Of The National Academy Of Sciences 106 (52), 22217-22222, 2009 | 142 | 2009 |
| Extracellular signal-regulated kinase, Jun N-terminal kinase, p38, and c-Src are involved in gonadotropin-releasing hormone-stimulated activity of the glycoprotein hormone … D Bonfil, D Chuderland, S Kraus, D Shahbazian, I Friedberg, R Seger, ... Endocrinology 145 (5), 2228-2244, 2004 | 115 | 2004 |
| MEK targeting in N-RAS mutated metastatic melanoma J Thumar, D Shahbazian, SA Aziz, LB Jilaveanu, HM Kluger Molecular cancer 13 (1), 45, 2014 | 84 | 2014 |
| Control of Paip1-eukayrotic translation initiation factor 3 interaction by amino acids through S6 kinase Y Martineau, X Wang, T Alain, E Petroulakis, D Shahbazian, B Fabre, ... Molecular and Cellular Biology 34 (6), 1046-1053, 2014 | 52 | 2014 |
| Identification of novel radiosensitizers in a high-throughput, cell-based screen for DSB repair inhibitors AG Goglia, R Delsite, AN Luz, D Shahbazian, AF Salem, RK Sundaram, ... Molecular cancer therapeutics 14 (2), 326-342, 2015 | 51 | 2015 |
| mTOR signaling: implications for cancer and anticancer therapy. E Petroulakis, Y Mamane, O Le Bacquer, D Shahbazian, N Sonenberg British journal of cancer 96, R11-5, 2007 | 43 | 2007 |
| Vertical pathway targeting in cancer therapy D Shahbazian, J Sznol, HM Kluger Advances in pharmacology 65, 1-26, 2012 | 25 | 2012 |
| Radiation sensitivity and sensitization in melanoma D Shahbazian, RS Bindra, HM Kluger, PM Glazer Pigment cell & melanoma research 26 (6), 10.1111/pcmr. 12147, 2013 | 12 | 2013 |
| Regular Articles-Immunology-The CC Chemokine RANTES in Breast Carcinoma Progression: Regulation of Expression and Potential Mechanisms of Promalignant Activity. E Azenshtein, G Luboshits, S Shina, E Neumark, D Shahbazian, M Weil, ... Cancer Research 62 (4), 1093-1102, 2002 | 4 | 2002 |
| RNA helicases and their cofactors D Shahbazian, J Pelletier, Y Svitkin, JWB Hershey, A Parsyan Translation and Its Regulation in Cancer Biology and Medicine, 115-134, 2014 | 1 | 2014 |
